Searching the RRID Resource Information Network
Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.
SciCrunch Registry is a curated repository of scientific resources, with a focus on biomedical resources, including tools, databases, and core facilities - visit SciCrunch to register your resource.
| Resource Name | Proper Citation | Abbreviations | Resource Type |
Description |
Keywords | Resource Relationships | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
European Federation of Pharmaceutical Industries and Associations Resource Report Resource Website 10+ mentions |
European Federation of Pharmaceutical Industries and Associations (RRID:SCR_003820) | EFPIA | institution | Federation representing the pharmaceutical industry operating in Europe. Through its direct membership of 33 national associations and 40 leading pharmaceutical companies, it is the voice on the EU scene of 1,900 companies committed to researching, developing and manufacturing new medical treatments. In addition, it is active in partnering in EU Research programmes, such as the IMI (Innovative Medicines Initiative), Europe's largest public-private partnerships. They also work on corporate social responsibility initiatives with others healthcare stakeholders, such as patient groups and healthcare professionals. EFPIA has specialized committees and task forces focused on key areas of activity. EFPIA also includes two specialized groups focusing on vaccines and biotechnology, respectively: * Vaccines Europe (formerly European Vaccine Manufacturers, EVM) produces approximately 80% of vaccines used worldwide * European Biopharmaceutical Enterprises (EBE) harness biotechnology to develop approximately one-fifth of new medicines | pharmaceutical, medicine, vaccine, biotechnology, manufacturing, corporate |
is affiliated with: Merck is affiliated with: Roche is related to: Innovative Medicines Initiative is parent organization of: Innovative Medicines Initiative |
nlx_158124, grid.484123.8, ISNI: 0000 0000 9246 8110, Wikidata: Q1376562 | https://ror.org/00g1x4v36 | SCR_003820 | 2026-08-01 12:02:20 | 12 | ||||||||
|
Avid Radiopharmaceuticals Resource Report Resource Website |
Avid Radiopharmaceuticals (RRID:SCR_003786) | commercial organization | Subsidiary of Eli Lilly and Company who develops new molecular imaging agents capable of changing the medical management of significant, chronic human diseases by identifying the first stages of pathological change, potentially assisting in earlier diagnosis, and better management and development of new therapies. The company has developed a radioactive tracer called florbetapir (18F). Florbetapir can be used to detect beta amyloid plaques in patients with memory problems using positron emission tomography (PET) scans, making the company the first to bring to market an FDA-approved method that can directly detect this hallmark pathology of Alzheimer's disease. | molecular imaging agent, beta amyloid plaque, pet | Alzheimer's disease | nlx_158076 | SCR_003786 | Avid Radiopharmaceuticals Inc. | 2026-08-01 12:02:33 | 0 | |||||||||
|
Asthma UK Resource Report Resource Website 10+ mentions |
Asthma UK (RRID:SCR_003815) | Asthma UK | institution | Charity that aims to significantly reduce the number of asthma deaths, hospitalizations and living lives compromised by asthma helping over five million people with asthma in the UK through research, campaigning, health promotion and engagement with the asthma community. Asthma UK is a significant investor in asthma research within the UK and to date has invested over 50 million pounds into research for better treatments and ultimately a cure for asthma. | lung, treatment | is parent organization of: EARIP | Asthma | Crossref funder ID: 501100000362, ISNI: 0000 0000 9981 854X, nlx_158172, grid.453156.0 | https://ror.org/03z7xev21 | SCR_003815 | 2026-08-01 12:02:33 | 12 | |||||||
|
EURORDIS Resource Report Resource Website 10+ mentions |
EURORDIS (RRID:SCR_003814) | EURORDIS | nonprofit organization | EURORDIS is a non-governmental patient-driven alliance of patient organizations and individuals active in the field of rare diseases, dedicated to improving the quality of life of all people living with rare diseases in Europe. It is a not-for-profit organization and represents more than 479 rare disease organizations in 45 different countries (of which 25 are EU Member States), covering more than 4,000 rare diseases. It is therefore the voice of the 30 million patients affected by rare diseases throughout Europe. EURORDIS aims at improving the quality of life of people living with rare diseases in Europe through advocacy at the European level, support for research and drug development, networking patient groups, raising awareness and other actions designed to fight against the impact of rare diseases on the lives of patients and family. EURORDIS' training programs and resources are designed to strengthen the capacity of rare disease patients' representatives. Training empowers patients' representatives to advocate effectively for rare diseases at both the local and EU level. Key issues affecting patients of Rare Diseases on which we actively work: * Sustaining rare diseases as an EU public health priority * Making Rare Diseases A Public Health Priority In All Member States * Rare Diseases: An International Public Health Priority * Improving Access To Orphan Drugs * Improving Access To Quality Care * Promoting cross-border healthcare and patient mobility * Bridging Patients And Research * Genetic testing and newborn screening | French Muscular Dystrophy Association ; European Union ; members ; corporate foundations ; health industry |
Wikidata: Q5412882, grid.433753.5, nlx_143535 | https://ror.org/019w4mg02 | SCR_003814 | EURORDIS - Rare Diseases Europe | 2026-08-01 12:02:26 | 38 | ||||||||
|
Alzheimer's Research UK Resource Report Resource Website 10+ mentions |
Alzheimer's Research UK (RRID:SCR_003847) | ARUK | nonprofit organization | The UK's leading dementia research charity that funds world-class, pioneering scientists at leading universities to find preventions, treatments and a cure for dementia. | late adult human, treat, prevent, alzheimer, dementia, portal, funding resource | Alzheimer's disease, Dementia | ISNI: 0000 0000 9689 1581, Crossref funder ID: 501100002283, Wikidata: Q2840694, nlx_158161, grid.453466.6 | https://ror.org/02ymzm013 | SCR_003847 | Alzheimers Research UK | 2026-08-01 12:02:21 | 15 | |||||||
|
Big Data Public Private Forum Resource Report Resource Website |
Big Data Public Private Forum (RRID:SCR_003837) | BIG | organization | A consortium working towards the definition and implementation of a clear strategy that tackles the necessary efforts of Big Data (in terms of research and innovation) while also providing supporting actions for the successful implementation of the Big Data economy. Building an industrial community around Big Data in Europe is the priority of this project, together with setting up the necessary collaboration and dissemination infrastructure to link technology suppliers, integrators and leading user organizations. | consortium, device development, data sharing, big data |
is listed by: Consortia-pedia is affiliated with: National University of Ireland; Galway; Ireland is affiliated with: University of Leipzig; Saxony; Germany has parent organization: German Research Center for Artificial Intelligence; Berlin; Germany |
European Union FP7 318062 | nlx_158150 | SCR_003837 | Big Data Public-Private Forum, BIG Project - Big Data Public-Private Forum, BIG Project, BIG consortium, Big Data Public Private Forum (BIG) | 2026-08-01 12:02:26 | 0 | |||||||
|
Nephropath Resource Report Resource Website 1+ mentions |
Nephropath (RRID:SCR_003995) | Nephropath | commercial organization | Commercial service interpreting renal biopsies using 14 board-certified, fellowship-trained pathologists with decades of experience. They provide doctors with a high quality, clinico-pathologic discussion by the pathologist that read the case. It is their goal to help equip doctors with the results they need to deliver the most effective patient care possible. That is why they deliver same-day biopsy results, including EM, because they know that time often has a critical effect on the outcome of many renal diseases. Nephropath also offers PLA2R serum testing and will soon be offering neuropathology services including muscle and nerve biopsy services.Nephropath is now Arkana Laboratories. | pathology, neuropathology, muscle, nerve, biopsy service, pathologist, kidney, biopsy, renal, serum, neurology | is related to: Kidney Health Initiative | Kidney disease | nlx_158408 | SCR_003995 | 2026-08-01 12:02:36 | 1 | ||||||||
|
Biomedicum Genomics Resource Report Resource Website |
Biomedicum Genomics (RRID:SCR_003907) | BMGen | commercial organization | Organization that provides academic and industrial clients access to functional genomics technologies, services and partnering solutions including genome-wide expression, copy number profiling, miRNA expression, DNA-protein interaction (ChIP-on-chip), Illumina high-throughput sequencing including nucleic acid quality and quantity assessment. For gene silencing and ectopic expression purposes, they offer high-titer shRNA and ORF lentiviruses targeting genes of interest. They also offer customized services e.g. preparation of gain or loss-of-function cell lines and protein interactomics-based services (yeast two-hybrid). In addition, they provide access to wide array of computational data analyses. BMGen also offers partnering deals for clients interested in customized integration of several technologies. | genomics, functional genomics, genome-wide expression, copy number profiling, mirna expression, dna-protein interaction, chip-on-chip, illumina, high-throughput sequencing, nucleic acid, quality assessment, quantity assessment, data analysis | is related to: PREDECT | nlx_158263 | http://www.bmgen.fi | SCR_003907 | Biomedicum Genomics Ltd, Biomedicum Genomics Oy | 2026-08-01 12:02:23 | 0 | |||||||
|
Microsens Resource Report Resource Website |
Microsens (RRID:SCR_003906) | Microsens | commercial organization | Commercial organization specializing in bacterial detection including tuberculosis, therapeutic protein and protein aggregation diseases. * Tools for rapid and simple bacteria and virus extraction including tuberculosis * Seprion technology for the detection and study of protein aggregates and protein aggregation diseases * LiMA technology for the ultra sensitive detection of bacteria and bacterial contamination | virus, protein aggregate, protein, therapeutic protein | is related to: Predict-TB | Tuberculosis, Protein aggregation disease | nlx_158251 | SCR_003906 | Microsens Diagnostics Ltd., Microsens Medtech Ltd, Microsens Medtech, Microsens Medtech Ltd. | 2026-08-01 12:02:35 | 0 | |||||||
|
Comprehensive Biomarker Center Resource Report Resource Website |
Comprehensive Biomarker Center (RRID:SCR_003901) | CBC | commercial organization | Commercial organization that discovers, validates & analyzes genomic biomarkers with a focus on body fluid samples. Take advantage of their proven expertise in biomarker signature development and speed up your biomarker studies. | biomarker, clinical research organization, genomic biomarker, genomic, diagnostic, testing, bodily fluid, clinical, dna, rna, dna extraction, rna extraction, microarray, next-generation sequencing, validation, microrna | is related to: READNA | nlx_158236 | SCR_003901 | febit, febit GmbH, Comprehensive Biomarker Center Gmbh | 2026-08-01 12:02:23 | 0 | ||||||||
|
Janssen Research and Development Resource Report Resource Website 1+ mentions |
Janssen Research and Development (RRID:SCR_003904) | Janssen R&D | commercial organization | Pharmaceutical company with a mission to discover and develop innovative medicines that ease patients'' suffering, and solve the most important unmet medical needs of our time. As one of the Janssen Pharmaceutical Companies, their strategy is to identify the biggest unmet medical needs and match them with the best science, internal or external, to find solutions for patients worldwide. They leverage their world-class discovery and development expertise, and operational excellence, to bring innovative, effective treatments in five therapeutic areas: cardiovascular and metabolism, immunology, infectious diseases and vaccines, neuroscience, and oncology. | pharmaceutical, oncology, immunology, neuroscience, vaccine, medical |
is related to: Investigator Databank is related to: eTRIKS is related to: Predict-TB is related to: OncoTrack is related to: European Lead Factory is related to: EU-AIMS is related to: GetReal is related to: Kinetics for Drug Discovery is related to: MIP-DILI is related to: NEWMEDS is related to: ORBITO is related to: PharmaCog is related to: PREDECT is related to: Structural Genomics Consortium is related to: Open PHACTS is related to: EMIF is parent organization of: Investigator Databank |
Infectious disease, Cardiovascular disease, Metabolic disease, Immunological disorder, Cancer | nlx_158241 | SCR_003904 | Janssen Research & Development LLC, Janssen Research & Development | 2026-08-01 12:02:23 | 2 | |||||||
|
FlexGen Resource Report Resource Website 1+ mentions |
FlexGen (RRID:SCR_003902) | FlexGen | commercial organization | A biotechnology company that has developed technology for synthesizing custom microarrays, the FlexArrayer. Its is a desk-top sized instrument which allows the researcher to generate, in their own laboratory, either a custom oligonucleotide array in a single day or oligonucleotide pool in a few days. Recent developments in synthesis chemistry allows many modifications to be incorporated or for alternative chemistries to be considered., THIS RESOURCE IS NO LONGER IN SERVICE. Documented on September 16,2025. | biotechnology, microarray, custom oligonucleotide array, oligonucleotide pool, oligonucleotide, gene, probe synthesis, target enrichment, probe design, biomolecule, dna sequencing, oligonucleotide synthesis, re-sequencing | is related to: READNA | THIS RESOURCE IS NO LONGER IN SERVICE | nlx_158237 | SCR_003902 | FlexGen B.V. | 2026-08-01 12:02:27 | 6 | |||||||
|
Hospira Resource Report Resource Website 100+ mentions |
Hospira (RRID:SCR_003985) | Hospira | commercial organization | American global pharmaceutical and medical device company with headquarters in Lake Forest, Illinois.Provider of injectable drugs and infusion technologies and global leader in biosimilars. From September 2015 Hospira is part of Pfizer. | drug, infusion pump, software, device, contract manufacturing, clinical, intravenous set |
is related to: Kidney Health Initiative is related to: Pfizer Inc. |
nlx_158395 | SCR_003985 | Hospira Inc., | 2026-08-01 12:02:29 | 122 | ||||||||
|
Quartz Bio Resource Report Resource Website |
Quartz Bio (RRID:SCR_003919) | QBIO | commercial organization | A Swiss service and consulting company specialized in the computational analysis of biomarker data from clinical trials. Their technical expertise spans across multiple biomaker technological platforms such as genetics, transcriptomics, protein assays and cellular assays. Quartz Bio is a spin-off of Merck Serono with the capital of the company entirely owned by its employees. | clinical, bioinformatics, medicine, biomarker, clinical trial, data analysis | is related to: PRECISESADS | nlx_158280 | SCR_003919 | Quartz Bio S.A. | 2026-08-01 12:02:35 | 0 | ||||||||
|
Althia Resource Report Resource Website |
Althia (RRID:SCR_003918) | Althia | commercial organization | A biomedical company in Spain focused on the development of new tools for diagnosis and personalized treatment of oncological diseases and precancerous. It has three areas of activity in permanent innovation: Assistance in Diagnosis / Prognosis in solid and hematological tumors, Translational Research covering the gap between basic and clinical research and advanced radiotherapy treatments based image-guided single dose (SD-IGRT). Their objectives are: * Provide an integrated tissue and tumor molecular phenotype analysis using the most advanced technologies in diagnosis, to guide the most appropriate treatment for each patient. * Discover and validate molecular patterns by molecular systems and platforms including pathology, to generate predictive algorithms through computational biology, evolution and determining the response of patients with a particular tumor profile. Althia has laboratories equipped with the most advanced equipment and technologies in Barcelona and Granada Genyo Center, with offices in Madrid. | oncology, diagnosis, prognosis, solid tumor, hematological tumor, translational, radiation, phenotype, analysis, pathology, hematology, hereditary | is related to: PRECISESADS | Cancer, Tumor, Solid tumor, Hematological tumor, Precancer | nlx_158279 | SCR_003918 | Althia Health Ltd., Althia Health, Advanced Laboratories of Translational Health, SL, S.L. | 2026-08-01 12:02:28 | 0 | |||||||
|
Cornell University; New York; USA Resource Report Resource Website 1+ mentions |
Cornell University; New York; USA (RRID:SCR_003998) | Cornell | university | Private and statutory Ivy League research university in Ithaca, New York. Founded in 1865 by Ezra Cornell and Andrew Dickson White, the university was intended to teach and make contributions in all fields of knowledge—from the classics to the sciences, and from the theoretical to the applied. |
uses: ReadCube uses: Scizzle uses: Writefull is affiliated with: PAMGO is parent organization of: MacCHESS is parent organization of: National Biomedical Center for Advanced ESR Technology is parent organization of: HINT is parent organization of: PHAST is parent organization of: Cornell University Neuroscience is parent organization of: PGN is parent organization of: DataStaR is parent organization of: arXiv is parent organization of: Weill Cornell Medicine Department of Neurology is parent organization of: Cornell University College of Veterinary Medicine Program of Study is parent organization of: PPDB: Plant Proteomics Database is parent organization of: Tetrahymena Stock Center is parent organization of: Cross-National Equivalent Files is parent organization of: Northeastern Collaborative Access Team is parent organization of: T-REX is parent organization of: Boyce Thompson Institute for Plant Research is parent organization of: Survey Research Institute is parent organization of: Cornell University College of Veterinary Medicine is parent organization of: Weill Cornell Medical College; New York; USA is parent organization of: Cornell University Labs and Facilities is parent organization of: DsTool is parent organization of: Sigpath is parent organization of: G-Protein Coupled Receptor Oligomerization Knowledge Base (GPCR-OKB) ontology project is parent organization of: Gramene is parent organization of: Assembly Likelihood Estimator is parent organization of: ALCHEMY is parent organization of: Plant Ontology is parent organization of: German Socio-Economic Panel is parent organization of: Raven is parent organization of: Cornell University BRC Epigenomics Core Facility is parent organization of: Cornell University Weill Medical College Human Immune Monitoring Core Facility is parent organization of: Cornell University BRC Genomics Core Facility is parent organization of: Cornell University BRC Proteomics and Metabolomics Core Facility is parent organization of: Cornell University BRC Imaging Core Facility is parent organization of: Cornell University BRC Flow Cytometry Core Facility is parent organization of: Cornell University BRC Bioinformatics Core Facility is parent organization of: Cornell University Biotechnology Resource Center Transcriptional Regulation and Expression Core Facility is parent organization of: Cornell University BRC Genomics Innovation Hub Core Facility is parent organization of: Cornell University Biotechnology Resource Center Biomolecular Interactions and Properties Core Facility is parent organization of: Cornell University Chemistry MS Core Facility is parent organization of: Cornell University NMR Core Facility has organization facet: RavenPro |
ISNI:000000041936877X, Crossref funder ID:100007231, grid.5386.8, nlx_58666, Wikidata:Q49115 | https://ror.org/05bnh6r87 | SCR_003998 | Cornell University | 2026-08-01 12:02:36 | 5 | ||||||||
|
NxStage Medical Resource Report Resource Website 1+ mentions |
NxStage Medical (RRID:SCR_004000) | NXTM, NxStage | commercial organization | A medical device company that develops, manufactures and markets innovative dialysis systems for the treatment of end-stage renal disease, or ESRD, and acute kidney failure. | medical device, kidney, dialysis, hemodialysis, home hemodialysis | is related to: Kidney Health Initiative | End-stage renal disease, Acute kidney failure | nlx_158411 | SCR_004000 | NxStage Medical Inc, NxStage Medical Inc. | 2026-08-01 12:02:26 | 1 | |||||||
|
Sirius Analytical Resource Report Resource Website |
Sirius Analytical (RRID:SCR_003945) | Sirius | commercial organization | Organization that designs and manufactures analytical instrumentation to measure physicochemical parameters for the pharmaceutical and biotech industry, as well as offers physicochemical data and consultancy services. Their instruments provide accurate and reliable values for pKa, log P, log D, solubility and dissolution, particle size and shape analysis. These critical physicochemical parameters are important in drug formulation, and also influence the ability of New Chemical Entities to cross biological membranes such as the gastro-intestinal tract, blood-brain barrier, skin and cell walls. Sirius also offers an analytical service for high quality PhysChem outsourcing, used by hundreds of clients worldwide. | measurement, instrument, chemical analysis, physicochemical, drug, small molecule, biotherapeutics, surface imaging, size, shape, drug development | is related to: ORBITO | nlx_158338 | http://www.sirius-analytical.com/ | SCR_003945 | Sirius - The Science of Measurement, Sirius Analytical Instruments Ltd., Sirius Analytical Ltd | 2026-08-01 12:02:28 | 0 | |||||||
|
Almirall Resource Report Resource Website 1+ mentions |
Almirall (RRID:SCR_003947) | Almirall | commercial organization | A pharmaceutical company committed to provide valuable medicines through their own R&D efforts, licenses and collaborations. Through seeking innovative medicines they aim to become a relevant player in respiratory and dermatology diseases with also a strong interest in gastroenterology and pain. The company is headquartered in Barcelona, Spain, and has 14 affiliates in Europe and North America and trading capacity in 22 countries. | gastroenterology, respiratory, dermatology, pharmaceutical, medicine, drug | is related to: Open PHACTS | Respiratory disease, Dermatologic disease, Pain, Gastrointestinal disease, Gastrointestinal condition | nlx_158340 | SCR_003947 | S.A., Laboratories Almirall S.A., Almirall | 2026-08-01 12:02:24 | 4 | |||||||
|
Simulations Plus Resource Report Resource Website 10+ mentions |
Simulations Plus (RRID:SCR_003946) | commercial organization | Commercial developer of Absorption, Distribution, Metabolism, Excretion and Toxicity (ADMET) and Physiologically-Based Pharmacokinetic (PBPK) modeling and simulation software for the pharmaceutical and biotechnology, industrial chemical, cosmetic, herbicide, and food ingredient industries. Their software allows pharmaceutical scientists to predict certain key potential endpoints and dynamics, in silico, thereby reducing research & development costs and helping clients make better projects decisions sooner. Consulting services: Their team of highly-skilled scientists is available to assist with your discovery and development activities on a project-by-project basis. They now offer expanded pharmacodynamic modeling services, NONMEM analysis, and regulatory report writing assistance. Their ultimate goal is to develop tools and systems which bridge PBPK modeling with clinical trial data analysis. Training workshops & User Groups: they offer hands-on introductory and advanced training workshops in the United States, Europe, and Asia throughout the year. | pharmaceutical, modelling, simulation, pharmacodynamic, biotechnology, chemical, cosmetic, food ingredient, herbicide, drug development, drug, pharmacokinetic | is related to: ORBITO | License required | nlx_158339, ISNI: 0000 0004 0506 5380, grid.418738.1, Wikidata: Q7521341 | https://ror.org/02p0yhm49 | SCR_003946 | Simulations Plus Inc. | 2026-08-01 12:02:35 | 33 |
Can't find your Tool?
We recommend that you click next to the search bar to check some helpful tips on searches and refine your search firstly. Alternatively, please register your tool with the SciCrunch Registry by adding a little information to a web form, logging in will enable users to create a provisional RRID, but it not required to submit.
Welcome to the ASWG Resources search. From here you can search through a compilation of resources used by ASWG and see how data is organized within our community.
You are currently on the Community Resources tab looking through categories and sources that ASWG has compiled. You can navigate through those categories from here or change to a different tab to execute your search through. Each tab gives a different perspective on data.
If you have an account on ASWG then you can log in from here to get additional features in ASWG such as Collections, Saved Searches, and managing Resources.
Here is the search term that is being executed, you can type in anything you want to search for. Some tips to help searching:
If you are logged into ASWG you can add data records to your collections to create custom spreadsheets across multiple sources of data.
Here are the facets that you can filter the data by.
If you have any further questions please check out our FAQs Page to ask questions and see our tutorials. Click this button to view this tutorial again.
Welcome to the ASWG Community.
Our Information
